Key result
Continuous-flow ventricular assist devices reduce or eliminate palpable pulses, rendering standard noninvasive monitors like pulse oximeters and automated blood pressure cuffs inaccurate.
Continuous-flow ventricular assist devices present unique monitoring challenges due to reduced arterial pulsatility, requiring specialized clinical assessment techniques outside the ICU.
Answers are grounded in this paper and cite their sources.
Standard monitors unreliable in continuous-flow VAD patients; leaves open validation of pulsatility-independent techniques in prospective studies.
Ventricular assist devices provide therapeutic options for patients with severe heart failure who have exhausted available medical therapies. With restoration of organ perfusion with ventricular assist devices, the heart failure resolves and quality of life and functional status improve. The current generation of continuous-flow devices present novel challenges to the clinical assessment of patients by substantially reducing or nearly eliminating any palpable pulse. Patients therefore generally have inadequate arterial pulsatility for most noninvasive monitoring devices such as pulse oximeters or automated blood pressure cuffs to work accurately. This article describes the function of continuous-flow devices and how this function affects common monitoring options, as well as how to clinically assess recipients of continuous-flow devices to promptly identify those whose condition may be deteriorating or who may be receiving inadequate perfusion.
No takes yet. Share an insight, caveat, or question.
O’Shea et al. (2013) studied this question. Continuous-flow ventricular assist devices reduce or eliminate palpable pulses, rendering standard noninvasive monitors like pulse oximeters and automated blood pressure cuffs inaccurate.
Synapse has enriched 10 related papers. Consider them for comparative context: